Vladimir Vexler Coherus Bio Sciences, Inc. (CHRS) insider trading activity

Vladimir Vexler is Chief Scientific Officer of Coherus BioSciences, Inc.. Currently has a direct ownership of 116,361 shares of CHRS, which is worth approximately $176,868. The most recent transaction as insider was on Mar 31, 2023, when has been sold 16,278 shares (Common Stock) at a price of $6.84 per share, resulting in proceeds of $111,341. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 116K

0% 3M change

0% 12M change

Total Value Held $176,868

Vladimir Vexler Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 31 2023	SELL Payment of exercise price or tax liability	$111,341 $6.84 p/Share	16,278 Reduced 12.27%	116,361 Common Stock
Jan 20 2023	BUY Grant, award, or other acquisition	-	40,000 Added 23.35%	131,323 Common Stock
Jan 11 2023	SELL Payment of exercise price or tax liability	$36,956 $10.26 p/Share	3,602 Reduced 3.79%	91,323 Common Stock
Jan 10 2023	SELL Payment of exercise price or tax liability	$35,479 $9.85 p/Share	3,602 Reduced 3.66%	94,925 Common Stock
Jan 04 2023	SELL Payment of exercise price or tax liability	$53,663 $9.87 p/Share	5,437 Reduced 5.23%	98,527 Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$44,435 $12.85 p/Share	3,458 Reduced 3.22%	103,963 Common Stock
Jan 11 2022	SELL Payment of exercise price or tax liability	$51,452 $14.36 p/Share	3,583 Reduced 3.23%	107,421 Common Stock
Jan 10 2022	SELL Payment of exercise price or tax liability	$59,345 $14.3 p/Share	4,150 Reduced 3.6%	111,004 Common Stock
Jan 04 2022	BUY Grant, award, or other acquisition	-	40,000 Added 25.78%	115,154 Common Stock
Apr 28 2021	BUY Grant, award, or other acquisition	-	20,000 Added 21.42%	73,386 Common Stock
Mar 09 2021	SELL Open market or private sale	$1,856,400 $16.25 p/Share	114,240 Reduced 68.15%	53,386 Common Stock
Mar 09 2021	BUY Exercise of conversion of derivative security	$731,707 $7.14 p/Share	102,480 Added 37.94%	167,626 Common Stock
Jan 11 2021	BUY Grant, award, or other acquisition	-	31,250 Added 32.42%	65,146 Common Stock
Jan 10 2021	SELL Payment of exercise price or tax liability	$74,174 $18.18 p/Share	4,080 Reduced 10.74%	33,896 Common Stock
Dec 10 2020	SELL Open market or private sale	$318,149 $18.05 p/Share	17,626 Reduced 32.46%	36,673 Common Stock
Dec 10 2020	BUY Exercise of conversion of derivative security	$36,662 $2.08 p/Share	17,626 Added 24.51%	54,299 Common Stock
Dec 09 2020	SELL Open market or private sale	$903,099 $18.24 p/Share	49,512 Reduced 57.45%	36,673 Common Stock
Dec 09 2020	BUY Exercise of conversion of derivative security	$62,400 $2.08 p/Share	30,000 Added 25.82%	86,185 Common Stock

Vladimir Vexler

Chief Scientific Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CHRS shares.

Notify only if

Value

Insider Trading

Get notified when an Coherus Bio Sciences, Inc. insider buys or sells CHRS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Coherus BioSciences, Inc.

Track Activities on CHRS

Account